Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Debt / NOTE 1.750% 6/1
-
Unit price / market price
-
$0.9703
-
Total 13F principal
-
$543,071,999
-
Principal change
-
+$28,255,999
-
Total reported value
-
$527,593,360
-
Number of holders
-
44
-
Value change
-
+$26,084,539
-
Number of buys
-
15
-
Number of sells
-
22
Institutional Holders of IONIS PHARMACEUTICALS INC - NOTE 1.750% 6/1 as of Q1 2025
As of 31 Mar 2025 IONIS PHARMACEUTICALS INC - NOTE 1.750% 6/1 had 44 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of $543,071,999 principal (par value or face value) of the bond of the company.
Largest 10 bondholders included CAMDEN ASSET MANAGEMENT L P /CA, Voya Investment Management LLC, WOLVERINE ASSET MANAGEMENT LLC, LAZARD ASSET MANAGEMENT LLC, WELLINGTON MANAGEMENT GROUP LLP, ADVENT CAPITAL MANAGEMENT /DE/, MACKAY SHIELDS LLC, BlackRock, Inc., Calamos Advisors LLC, and BANK OF MONTREAL /CAN/.
This table shows 44 bond principal holders of the security as of 31 Mar 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.